These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 29386825)
21. Treatment of Melasma with the Photoacoustic Twin Pulse Mode of Low-Fluence 1,064 nm Q-Switched Nd:YAG Laser. Kim JY; Choi M; Nam CH; Kim JS; Kim MH; Park BC; Hong SP Ann Dermatol; 2016 Jun; 28(3):290-6. PubMed ID: 27274626 [TBL] [Abstract][Full Text] [Related]
22. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy. Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369 [TBL] [Abstract][Full Text] [Related]
23. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study. Zhou Y; Li Y; Hamblin MR; Wen X Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of low-fluence 1064 nm Q-switched Nd: YAG laser for the treatment of melasma: A meta-analysis and systematic review. Chen J; Yu N; Peng L; Li H; Tang Y; Ou S; Zhu H J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35621242 [TBL] [Abstract][Full Text] [Related]
25. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study. Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567 [TBL] [Abstract][Full Text] [Related]
26. A prospective, split-face, double-blinded, randomized study of the efficacy and safety of a fractional 1064-nm Q-switched Nd:YAG laser for photoaging-associated mottled pigmentation in Asian skin. Won KH; Lee SH; Lee MH; Rhee DY; Yeo UC; Chang SE J Cosmet Laser Ther; 2016 Nov; 18(7):381-386. PubMed ID: 27249461 [TBL] [Abstract][Full Text] [Related]
27. Low Fluence Q-Switched Nd: YAG Laser Toning and Q-Switched Ruby Laser in the Treatment of Melasma:A Comparative Split-Face Ultrastructural Study. Omi T; Yamashita R; Kawana S; Sato S; Naito Z Laser Ther; 2012 Mar; 21(1):15-4. PubMed ID: 24610976 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. Lee DB; Suh HS; Choi YS J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244 [TBL] [Abstract][Full Text] [Related]
29. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians. Jun HJ; Cho SH; Lee JD; Kim HS Lasers Med Sci; 2014 May; 29(3):1153-8. PubMed ID: 24292155 [TBL] [Abstract][Full Text] [Related]
30. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Jalaly NY; Valizadeh N; Barikbin B; Yousefi M Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737 [TBL] [Abstract][Full Text] [Related]
31. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. Vachiramon V; Sirithanabadeekul P; Sahawatwong S J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592 [TBL] [Abstract][Full Text] [Related]
32. Intense Pulsed Light and Low-Fluence Q-Switched Nd:YAG Laser Treatment in Melasma Patients. Na SY; Cho S; Lee JH Ann Dermatol; 2012 Aug; 24(3):267-73. PubMed ID: 22879709 [TBL] [Abstract][Full Text] [Related]
33. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? Gokalp H; Akkaya AD; Oram Y J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828 [TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser. Geddes ER; Stout AB; Friedman PM Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994 [TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combination of Q-Switched Nd: YAG Laser and topical methimazole 5% in patients with refractory melasma. Beyzaee AM; Goldust M; Rokni GR; Patil A; Mostaghiman R; Golpour M J Cosmet Dermatol; 2023 Jun; 22(6):1774-1779. PubMed ID: 36847668 [TBL] [Abstract][Full Text] [Related]
36. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up. Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323 [TBL] [Abstract][Full Text] [Related]
37. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Moubasher AE; Youssef EM; Abou-Taleb DA Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574 [TBL] [Abstract][Full Text] [Related]
39. Successful Treatment of Riehl's Melanosis With Mid-Fluence Q-Switched Nd:YAG 1064-nm Laser. Cho MY; Roh MR Lasers Surg Med; 2020 Oct; 52(8):753-760. PubMed ID: 31951050 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial. Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]